Cargando…
Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
Gastric cancer (GC) is a leading cause of death. We aim to establish a clinically relevant assay that encompasses recent molecular classifications and provides useful clinical information in a large cohort of GC patients. A consecutive series of 438 GC patients that underwent palliative chemotherapy...
Autores principales: | Kim, Hyo Song, Shin, Su-Jin, Beom, Seung-Hoon, Jung, Minkyu, Choi, Yoon Young, Son, Taeil, Kim, Hyoung-Il, Cheong, Jae-Ho, Hyung, Woo Jin, Noh, Sung Hoon, Chung, Hyunsoo, Park, Jun Chul, Shin, Sung Kwan, Lee, Sang Kil, Lee, Yong Chan, Koom, Woong Sub, Lim, Joon Seok, Chung, Hyun Cheol, Rha, Sun Young, Kim, Hyunki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190122/ https://www.ncbi.nlm.nih.gov/pubmed/27331626 http://dx.doi.org/10.18632/oncotarget.10115 |
Ejemplares similares
-
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
por: Kim, Hyo Song, et al.
Publicado: (2017) -
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
por: Kim, Min Hwan, et al.
Publicado: (2019) -
Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer
por: Bae, Yoon Sung, et al.
Publicado: (2015) -
Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
por: Kim, Yuna, et al.
Publicado: (2022) -
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)